Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00005723
DRKS00005723
Recruiting
Phase 1

Phase I Study with non-viral jet-injection-genetransfer of a TNF-alpha expressing MIDGE-vector in cutaneous metastases of malignant melanoma

Charité Campus Charité Mitte0 sites9 target enrollmentFebruary 17, 2014
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsC43Malignant melanoma of skin

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
C43
Sponsor
Charité Campus Charité Mitte
Enrollment
9
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 17, 2014
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Charité Campus Charité Mitte

Eligibility Criteria

Inclusion Criteria

  • •malignant melanoma with cutaneous metastases
  • •pretreated with DTIC

Exclusion Criteria

  • •cerebral metastases
  • •active infections

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Treatment with daratumumab injections in moderate to severe ME/CFSMyalgic Encephalomyelitis/Chronic Fatigue SyndromeMedDRA version: 20.1Level: LLTClassification code 10028414Term: Myalgic encephalomyelitisSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2022-000281-18-NOHaukeland University Hospital, Dept. of Oncology and Medical Physics10
Active, not recruiting
Phase 1
Daratumumab in ME/CFSMyalgic Encephalomyelitis/Chronic Fatigue SyndromeMedDRA version: 26.1Level: LLTClassification code: 10028414Term: Myalgic encephalomyelitis Class: 10021881Therapeutic area: Diseases [C] - Immune System Diseases [C20]
CTIS2024-512500-19-00Helse Bergen HF10
Not yet recruiting
Phase 1
Mesenchymal Stem Cell Therapy For Covid 19Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2020/08/027043eurogen Brain and Spine Institute
Completed
Phase 1
Phase 1 Clinical Trial of intra-thoracic administration of Zoredronic Acid in Subjects with Unresectable Malignant Pleural MesotheliomaMalignant Pleural Mesothelioma
JPRN-UMIN000008093Chiba University Hospital18
Terminated
Not Applicable
Jet Injection of 1% Buffered Lidocaine Versus Topical EMLA for Local Anesthesia Before Lumbar Puncture in ChildrenLumbar PunctureTopical Analgesia
NCT01628874University of Colorado, Denver66